Skip to main content

ORIGINAL RESEARCH article

Front. Bioeng. Biotechnol., 05 August 2022
Sec. Nanobiotechnology
This article is part of the Research Topic Smart Stimuli-responsive Biomaterials for Programmed Drug Delivery View all 12 articles

RETRACTED: Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy

Retracted
Maryamsadat ShahidiMaryamsadat Shahidi1Omid AbazariOmid Abazari1Parisa DayatiParisa Dayati2Ali BakhshiAli Bakhshi1Javad ZavarrezaJavad Zavarreza1Mohammad Hossein ModarresiMohammad Hossein Modarresi3Fateme Haghiralsadat
Fateme Haghiralsadat4*Mehdi RahmanianMehdi Rahmanian5Seyed Morteza Naghib
Seyed Morteza Naghib6*Davood Tofighi
Davood Tofighi7*
  • 1Department of Clinical Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran
  • 2Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  • 3Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • 4Department of Advanced Medical Sciences and Technologies, School of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • 5Biomaterials and Tissue Engineering Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
  • 6Nanotechnology Department, School of Advanced Technologies, Iran University of Science and Technology (IUST), Tehran, Iran
  • 7Department of Psychology, Epidemiology, and Research Design Support (BERD), Clinical and Translational Science Center, University of NM, Albuquerque, NM, United States

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Shahidi M, Abazari O, Dayati P, Bakhshi A, Zavarreza J, Modarresi MH, Haghiralsadat F, Rahmanian M, Naghib SM and Tofighi D (2022) Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy. Front. Bioeng. Biotechnol. 10:949704. doi: 10.3389/fbioe.2022.949704

Received: 21 May 2022; Accepted: 04 July 2022;
Published: 05 August 2022; Retracted: 21 August 2024.

Edited by:

Giada Graziana Genchi, Italian Institute of Technology (IIT), Italy

Reviewed by:

Wansong Chen, Central South University, China
Xianwen Wang, Anhui Medical University, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.